Literature DB >> 7688807

Inhibition of cardiac vagal action by galanin but not neuropeptide Y in the brush-tailed possum Trichosurus vulpecula.

G P Courtice1, E K Potter, D I McCloskey.   

Abstract

1. Stimulation of the right cardiac sympathetic nerve for 2 min at 16 Hz in the presence of either beta- or alpha- and beta-adrenoceptor blockade evoked attenuation of cardiac vagal action in eight possums: 31.3 +/- 10.3% maximum inhibition of cardiac vagal action on prolonging pulse interval, with a time to half-recovery of 4.9 +/- 1.1 min. 2. Intravenous injection of galanin (2-3.5 nmol kg-1) evoked similar inhibition of cardiac vagal action: 41.3 +/- 4.1% maximum inhibition of cardiac vagal action on pulse interval, with a time to half-recovery of 13.4 +/- 2.3 min. 3. Intravenous injection of neuropeptide Y (NPY) at greater molar doses (6.5-10 nmol kg-1) caused no inhibition of cardiac vagal action. 4. The galanin injections caused a powerful pressor response: 57.1 +/- 4.9 mmHg increase in systolic blood pressure. NPY caused a smaller pressor response, despite administration of higher molar doses: 36.7 +/- 3.0 mmHg increase in systolic blood pressure. 5. In the possum, galanin but not NPY can mimic the effects of cardiac sympathetic nerve stimulation on vagal action. Galanin also causes large pressor effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688807      PMCID: PMC1175262          DOI: 10.1113/jphysiol.1993.sp019518

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  23 in total

1.  Effect of neuropeptide-Y and galanin on autonomic control of heart rate in the toad, Bufo marinus.

Authors:  G P Courtice
Journal:  J Auton Nerv Syst       Date:  1991-05

2.  Galanin- and neuropeptide Y-like immunoreactivities coexist in paravertebral sympathetic neurones of the cat.

Authors:  W Kummer
Journal:  Neurosci Lett       Date:  1987-07-22       Impact factor: 3.046

3.  Neuropeptide Y-like immunoreactivity in bullfrog sympathetic ganglia is restricted to C cells.

Authors:  J P Horn; W D Stofer; S Fatherazi
Journal:  J Neurosci       Date:  1987-06       Impact factor: 6.167

Review 4.  Neuropeptide Y as an autonomic neurotransmitter.

Authors:  E K Potter
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

5.  Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.

Authors:  M R Warner; M N Levy
Journal:  Circ Res       Date:  1989-12       Impact factor: 17.367

6.  Prolonged inhibition of cardiac vagal action following sympathetic stimulation and galanin in anaesthetized cats.

Authors:  M Revington; E K Potter; D I McCloskey
Journal:  J Physiol       Date:  1990-12       Impact factor: 5.182

7.  Comparison of the inhibitory roles of neuropeptide Y and galanin on cardiac vagal action in the dog.

Authors:  M Moriarty; I L Gibbins; E K Potter; D I McCloskey
Journal:  Neurosci Lett       Date:  1992-05-25       Impact factor: 3.046

8.  Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y.

Authors:  E Potter
Journal:  Neurosci Lett       Date:  1987-12-16       Impact factor: 3.046

9.  Attenuation of long-lasting effects of sympathetic stimulation after repeated stimulation.

Authors:  G T Hall; T D Gardner; E K Potter
Journal:  Circ Res       Date:  1990-07       Impact factor: 17.367

10.  Dependence of non-adrenergic inhibition of cardiac vagal action on peak frequency of sympathetic stimulation in the dog.

Authors:  T D Gardner; E K Potter
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

View more
  2 in total

1.  Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse.

Authors:  Margaret A Smith-White; Tiina P Iismaa; Erica K Potter
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

2.  Selective regional vasoconstriction underlying pressor effects of galanin in anaesthetized possums compared with cats.

Authors:  G P Courtice; J R Hales; E K Potter
Journal:  J Physiol       Date:  1994-12-01       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.